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In cochlear development, the Notch signaling pathway is required for both the early prosensory phase and a later lateral inhibition phase. While
it is known that Hes genes are important downstream mediators of Notch function in lateral inhibition, it is not known what genes function as
mediators of the early prosensory function of Notch. We report that two members of the Hes-related gene family, Hesr1 and Hesr2, are expressed
in the developing cochlea at a time and place that makes them excellent candidates as downstream mediators of Notch during prosensory
specification. We also show that treatment of cochlear explant cultures at the time of prosensory specification with a small-molecule inhibitor of
the Notch pathway mimics the results of conditional Jag1 deletion. This treatment also reduces Hesr1 and Hesr2 expression by as much as 80%.
These results support the hypothesis that Hesr1 and Hesr2 are the downstream mediators of the prosensory function of Notch in early cochlear
development.
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The cochlea of the mammalian inner ear has a specialized
sensory epithelium, the organ of Corti that is responsible for the
perception of sound. During the development of the organ of
Corti, sensory hair cells, and adjacent supporting cells, develop
from a “prosensory” domain. The highly ordered array of hair
cells and supporting cells has served as an excellent model
system to analyze the role of Notch in lateral inhibition in the
vertebrate nervous system (Lai, 2004; Lewis et al., 1998; Louvi
and Artavanis-Tsakonas, 2006).
The development of the organ of Corti can be divided into
two phases. In the early, or “prosensory” phase, the sensory
epithelial domain of the cochlear duct is specified. In the second⁎ Corresponding author. Virginia Merrill Bloedel Hearing Research Center,
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doi:10.1016/j.ydbio.2008.01.006phase, the hair cells and their accompanying supporting cells
differentiate from the sensory epithelial domain (Kelley, 2006).
Several lines of evidence indicate that Notch is required during
both phases of inner ear development. The most well studied
role for Notch in cochlear development is in the second phase,
during the process of lateral inhibition. During lateral inhibition,
Delta1 (Dll1), Delta3 (Dll3) and Jagged2 (Jag2) are expressed
in the differentiating hair cells (Hartman et al., 2007; Morrison
et al., 1999) and signal to Notch-expressing supporting cells to
inhibit them from differentiating as hair cells (Lanford et al.,
1999). Conditional deletions in either the Jag2 or Dll1 genes in
the developing cochlea lead to overproduction of hair cells,
through a fate switch of supporting cells (Brooker et al., 2006;
Kiernan et al., 2005).
However, in addition to this lateral inhibitory function, recent
evidence supports a role for Notch signaling earlier in cochlear
development, during the prosensory phase. The Notch ligand
Jagged1 (Jag1) is expressed in the prosensory epithelium
88 T. Hayashi et al. / Developmental Biology 316 (2008) 87–99prior to hair cell differentiation; Jag1 mutants and conditional
Jag1 knockout mice have a loss of most of the hair cells and
supporting cells (Brooker et al., 2006;Morrison et al., 1999; Tsai
et al., 2001; Kiernan et al., 2006). Forced activation of Notch
signaling using a Notch intracellular domain (Notch-ICD)
expressing construct has two distinct, and contrasting effects,
on the development of the cochlea in chick embryos: Notch-ICD
expressed in the sensory patch inhibits the differentiation of hair
cells, while expression of Notch-ICD outside the normal sensory
epithelium causes ectopic patches of hair cells (Daudet and
Lewis, 2005).
The mechanism by which Notch activation can have these
two distinct effects is not clear. Presumably, these two distinct
functions are likely to require separable downstream effectors to
translate Notch activation into different transcriptional
responses. Once activated by one of its ligands, the intracellular
domain of Notch associates with RBPjK/SuH in the nucleus and
activates transcription of genes in the hairy/enhancer (Hes) of
split family (Bray, 2006). The gene products of the Hes family
are bHLH proteins that act as transcriptional repressors at
specific DNA sequences in the promoters of target genes. There
are three main subtypes in this family, the Hes genes (Hes1–
Hes7), the Hes related genes, Hesr1, Hesr2 and Hesr3 (also
known as Hey, Herp, Hrt, Chf and Gridlock), and the Dec
genes (Dec1 and Dec2) (Iso et al., 2003 for review). The Hes
genes, Hes1 and Hes5, have been previously shown to have a
role as critical transcriptional targets of the Notch pathway in
the lateral inhibitory phase of cochlear development. Deletions
in either gene produce additional rows of hair cells in the
cochlea (Zine et al., 2001). However, analogous target genes for
the Notch pathway during the earlier, prosensory phase of
cochlear development have not been identified.
To investigate this question, we analyzed the expression of
the Hesr genes, Hesr1, Hesr2 and Hesr3 in the developing
cochlea and we show that Hesr1 and Hesr2 are expressed at the
right time and place to act downstream of Notch for its
prosensory actions. By inhibiting Notch at specific phases of
cochlear development, we were able to experimentally dissect
the distinct prosensory and lateral inhibitory functions. We find
that both Hesr1 and Hesr2 are regulated during the prosensory
phase, supporting a role for these molecules in prosensory
specification.
Materials and methods
Mice
Timed pregnant matings of Swiss-Webster mice purchased from Harlan
(Indianapolis, IN) were housed in the Department of Comparative Medicine; all
procedures were carried out in accordance with the guidelines of the animal care
and use committee at the University of Washington. We used the staging system
of Theiler (Theiler, 1989) to accurately stage the embryos at the time of harvest
(http://genex.hgu.mrc.ac.uk/Atlas/intro.html). For the postnatal animals, P0 is
defined as the day of birth. Hesr1, Hesr2-knockout mice were housed in the
Division of Mammalian Development and procedures were carried out in
accordance with the guidelines of the animal care committee at the National
Institute of Genetics (Mishima, Japan). The generation and characterization of
these mice has been previously described (Kokubo et al., 2005a; Kokubo et al.,
2004). Whole heads of P3 pups were fixed with 4% paraformaldehyde (PFA)and then the cochlear ducts were dissected. To expose the organ of Corti, the
anlage of stria vascularis was removed using a fine forceps. Some cochlear ducts
were embedded in paraffin for sectioning and Hematoxylin–Eosin (HE)
staining.
Histology/in situ hybridization
Whole heads (E12.5–16.5 and E18.5) were fixed in a modified Carnoy's
solution for 6 h at room temperature. Inner ear tissues were also harvested from
P0 mice. The samples were washed and dehydrated in 100% ethanol overnight
at 4 °C, and then were embedded in paraffin and 6 μm sections were collected.
At least three animals were examined at each time point. Mouse Hesr1, Hesr2,
Hesr3, Math1, Jag1 and Hes5 cDNAs were obtained from Open Biosystems
Inc. (Huntsville, AL), and cDNA coding for mouse Sox2 was a gift from Hisato
Kondoh (Osaka University, Osaka, Japan). Digoxigenin (DIG)-labeled probes
were prepared according to the manufacturer's manual for DIG-11-UTP (Roche,
Indianapolis, IN) and the hybridization was carried out according to Hayashi et
al. (2007). The in situ product was visualized using anti-DIG alkaline
phosphatase conjugated secondary antibody (Roche) and NBT/BCIP.
Immunofluorescence
After in situ hybridization, the slides were fixed with 4% PFA for 1 h and
washed in PBS. The slides were then incubated with 10% fetal bovine serum and
2% nonfat dry milk in PBS/0.1% Triton X-100 (PBST) for 30 min. After an
overnight incubation with the primary antibody at 4 °C, the sections were rinsed
with PBST, incubated for 90 min with a fluorescent-conjugated secondary
antibody, rinsed with PBST, and coverslipped in Fluoromount G (Southern
Biotechnology, Birmingham, AL). Whole mount staining of cochleas was
carried out according to Hayashi et al. (2007). The primary antibodies used in
this study were as follows: rabbit anti-Prox1 (Chemicon, Temecula, CA) used at
1:300 (1:1000 for whole mount) dilution; mouse anti-p27kip1 (BD Transduction
Laboratories, San Diego, CA) at 1:300 dilution; rabbit anti-Myosin6 (Myo6) at
1:1000 dilution; goat anti-Sox2 (Santa Cruz, San Diego, CA) at 1:1000 dilution;
biotinylated Griffonia Simplicifolia (GS)-lectin (Vector Laboratories, Burlin-
game, CA) was used at 1:100 dilution. The secondary antibodies used were goat
anti-mouse Alexa 594, chicken anti-rabbit Alexa 594, donkey anti-goat Alexa
594 and streptavidin conjugated Alexa 488 all from Molecular Probes (Eugene,
OR) and used at 1:750. Images were captured on a Zeiss Axioplan microscope
using a SPOT CCD camera and processed using Adobe Photoshop.
Organ cultures of embryonic cochlea
Inner ear tissue was isolated from E12.5–E13.0 mice and separated into
cochlear and vestibular parts. The cochlea was treated with 0.1% Dispase
(GIBCO, Carlsbad, CA), 0.1% collagenase (GIBCO) and 0.001% DNase
(Sigma) for 15 min at 37 °C. The cochlear capsule was opened using forceps to
expose the cochlear duct. The cochlear ducts were placed on a collagen/Matrigel
substrate, along with the mesenchyme surrounding the cochlea. Cochleas were
cultured in modified DMEM: F12 media [DMEM: F12 (GIBCO), 0.6% glucose,
5 mM HEPES, 0.13% NaHCO3, 800 nM L-glutamine, 100 u/ml penicillin
(Sigma, St. Louis, MO), N2 supplement and 20% fetal bovine serum], 5% CO2,
at 37 °C and all media was replaced each day. To inhibit Notch signaling, 5–
50 μM of N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester
(DAPT; Calbiochem, San Diego, CA) or 20–100 μM of N-(R)-[2-(hydro-
xyaminocarbonyl)methyl]-4-methylpentanoyl-L-naphthylalanyl-L-alanine-2-
aminoethyl amide (TAPI-1; EMD Biosciences) were added to the culture
medium as a γ-secretase inhibitor (DAPT) or TNFa-converting enzyme (TACE)
inhibitor (TAPI-1). The cultured cochleas were fixed in 4% PFA, and the hair
cells were labeled by immunostaining using rabbit anti-Myo6 antibody. The
cochlear ducts shown in Figs. 7–9 were outlined using DAPI and Normarski
images.
Quantitative PCR (Q-PCR) analysis of cochlea RNA
Total RNAwas extracted from pools of 6–8 E12.5–E13.0 cochleas cultured
with/without DAPT using TRIzol (Invitrogen, Carlsbad, CA), and then the RNA
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pools were prepared for each experiment. cDNA was synthesized by
Superscript III reverse transcriptase (Invitrogen) using random primers and
2.5 μg total RNA as template, and RT-PCR reactions were carried out using the
cDNAs and the following primer sets (forward vs. reverse): Hesr1 (5′-
TGAGCTGAGAAGGCTGGTAC-3′, 5′-ACCCCAAACTCCGATAGTCC-3′),
Hesr2 (5′-TGAGAAGACTAGTGCCAACAGC-3′, 5′-TGGGCATCAAAG-
TAGCCTTTA-3′), GAPDH (5′-CGGAAGCCCGGGTCTTCTCAC-3′, 5′-
CGAACCGCGTCTCTTCTGCAGTG-3′). The PCR products were separated
by electrophoresis and stained with SYBR Safe (Molecular Probes).
Quantitative PCR was performed by using an Opticon monitor (Genetic
Technologies, Inc., Miami, FL), and the cycle in which log phase was attained
was recorded. A SYBR Green-based mastermix (Applied Biosystems, Foster
City, CA) was used for the PCR reactions. All samples were normalized to
expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Electroporation of organ cultures
Explants, prepared as above (the cochlear duct was opened to allow the
DNA solution to reach the surface of the sensory epithelium), were incubated for
4 h at 37 °C to allow attachment to the membrane coated with Collagen-
Matrigel. The explants were transferred to agarose plate filled with 0.6 ml of
HBSS. DNA solutions (10 μg/μl) were mixed with a equal amount of 50%
glycerol/2× PBS loading buffer to increase the density. Explants were positioned
sensory epithelium surface-up, and approx. 10 μl of DNA solution was pipette
onto the explant such that the solution flowed over the surface of the sensory
epithelium. The cochlear explant was oriented perpendicular to the surface of the
well and the two electrodes were placed on opposite sides of the explant.
Electroporation conditions were six pulses, 35 V, 75 ms, and applied with a
T820 square-wave electroporator (BTX, San Diego, CA). Transfected explants
were transferred into fresh media and cultured for 6 days at 37 °C. The dominant
negative MAML (human MAML1, aa 13–74; Nam et al., 2003; Weng et al.,
2003) was driven by combined cytomegalovirus immediate early enhancer
(CMV IE) and chicken beta-actin promoter, and IRES2–EGFP sequence was
inserted downstream of dnMAML to identify transfected cells.Results
Expression patterns of Hesr genes in the developing cochlea
We analyzed the expression of Hesr genes at several key
developmental stages, and compared their expression to that of
other markers of cochlear development. Both Hesr1 and Hesr2
are expressed in E12.5 and E13.5 cochlea. Hesr1 is expressed
as a broad band of labeled cells in the ventral side of the
developing cochlear duct (Figs. 1A, D), while Hesr2 is
expressed as a narrower band of labeled cells, nested in the
Hesr1 expressing region (Figs. 1B, E). At E14.5, in basal
regions of the cochlea, the area of Hesr1 expression is divided
into a robust band (Figs. 1F, H, brackets) and a region of faint
expression in the greater epithelial ridge (GER; Figs. 1F, H,
arrows). By E14.5 the Hesr2 expression becomes more intense
at all turns of the cochlea and overlaps almost entirely with the
Hesr1 expression domain (Fig. 1G). By E16.5, the expression
of Hesr2 is undetectable in the basal turn (Fig. 1I, open
arrowheads), but is still expressed in the apex. Hesr2
expression continues at the apex to E18.5 (Fig. 1K, closed
arrowhead), but is not detected in the postnatal cochlea. By
contrast, Hesr1 expression is detectable in all turns of the
cochlea at E16.5 (Fig. 1H), E18.5 (data not shown) and P0,
where it appears to be selectively expressed in the Deiters' cells
(Fig. 1J).Hesr3 mRNAwas not detected at E12.5 in the cochlear duct
(white arrowheads in Fig. 1C). In addition, Hesr3 was not
detected at E14.5 in the area of the developing sensory
epithelium delineated by immunostaining for p27kip1, a protein
that marks the area of the duct that gives rise to the sensory
epithelium (Chen and Segil, 1999; Lee et al., 2006) (Fig. 2A).
However, the expression of Hesr3 in the developing sensory
epithelium was clearly detected from E16.5 (Fig. 2B) and
interestingly, as Hesr2 expression is down-regulated at E16.5
and E18.5 (Figs. 1I and K), Hesr3 is expressed in the sensory
epithelium and GER (Figs. 2B and C). After birth, Hesr3 was
detected in the Deiters' cells, and the area of the inner hair cells,
inner phalangeal cells and cells in the GER, but not in pillar
cells (Fig. 2D).
Both Hesr1 mRNA and Hesr3 mRNA were detected in the
developing vestibular organs as early as E12.5 (see Supple-
mentary Figs. 1A,C). Hesr1 and Hesr3 were detected in all of
the sensory patches in the vestibular epithelium throughout
embryonic development and were largely overlapping in their
expression (Fig. S1D, F, G, I and data not shown). By
contrast, Hesr2 mRNA was not detected in the vestibular
system at any age examined (Fig. S1B, E, H and data not
shown).
Hesr1/2 expression precedes hair cell differentiation
We compared the expression of Hesr2 and markers of the
prosensory domain (Sox2), differentiating hair cells (Math1) or
Notch-signaling components (Jag1, Hes5) in E15.5 cochlea.
The Hesr2 expressing region (Fig. 3A) overlapped with the
prosensory domain marker Sox2 (Fig. 3B) andMath1 (Fig. 3C),
except in the most apical turn, where there was no detection of
Math1 mRNA at this age. Hesr2 is expressed in all turns of the
cochlea at E15.5 similar to Jag1 but Jag1 is also expressed in
cells medial to the Hesr2 expressing cells and the domain is
wider than that of Hesr2 in the basal turns (Fig. 3D). This
expression pattern is consistent with a role for Hesr2 down-
stream of Jag1 at the time of prosensory specification. By
contrast, neither Hes1 (Zheng et al., 2000) nor Hes5 (Fig. 3E)
are expressed in the apical turns at this stage, and they are just
beginning to be expressed in the basal turns. Hes1 and Hes5 are
expressed after Math1, whereas Hesr1 and Hesr2 are expressed
prior to the onset of Math1 expression.
To more precisely define the region of Hesr1 and Hesr2
expression, we post-labeled the in situ sections with antibodies
specific for p27kip1 an early marker of the sensory epithelium
(Chen and Segil, 1999). In the E13.5 cochlea, Hesr2, Jag1 and
Sox2 were expressed in a domain that included the domain of
p27kip1 labeling but extends more medially (Figs. 4E, G and I).
In addition, it appears that theHesr1 expression domain extends
over a somewhat broader area both medially and laterally. The
expression of these molecules occurs before the onset of
expression of Math1 (Fig. 4K). At E15.5, the expression of
Hesr1 is more restricted, now largely overlapping with the
expression of p27kip1 (Fig. 4E) but with some expression medial
to p27 kip1. Hesr1 expression overlaps with that of Jag1 and
Sox2 (Figs. 4H and J). At E15.5 Hesr2 has a more restricted
Fig. 1. Expression patterns of Hesr1 and Hesr2 in the developing cochlea. (A–E) Adjacent sections of the middle part of the E12.5 (A–C) and E13.5 (D,E) cochlear
duct. Expression of Hesr1 or Hesr2 is indicated by solid arrowheads. No expression in the prosensory domain was detected by Hesr3 probes at this stage (open
arrowhead in panel C). Adjacent sections of E14.5 (F, G), E16.5 (H, I) and E18.5 (K) cochlea. Levels (half-turns) of cochlear duct are numbered from base (turn 1) to
apex (turn 3 or turn 4). Open arrowheads in panels I and K indicate no expression. (J) Higher magnification micrograph of the basal turn (turn1) of P0 cochlea. Inset
shows entire cochlea. Arrowheads, arrow and brackets indicate expression domains. dc: Deiters' cells. hc: Hair cells. hens: Hensen's cells. Scale bar=100 μm.
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within the p27 kip1 domain and at this age Math1 expression is
clear (Figs. 4F and L). The expression of Hesr2 partly overlapswith Jag1, but Jag1 has a somewhat broader domain of
expression and is expressed more medially than Hesr2. In
addition this pattern of expression for Hesr2 looks similar to the
Fig. 3. Timing of Hesr2 relative to other marker genes expressed in the sensory
epithelium. Hesr2 (A) Sox2 (B), Math1 (C) and Notch signaling components,
Jag1 (D), Hes5 (E) in the E15.5 cochlea. Levels (half-turns) of the cochlear
duct are numbered from base (1) to apex (4).Hesr2, Sox2 and Jag1were express-
ed throughout (turn 1 to 4) the cochlea (arrowheads in panels A, B and D).Math1
and Hes5 were also expressed in the basal turns (arrowheads in panels C, E) but
not in the apical turns (open arrowheads in panels C, E). Scale bar=100 μm.
Fig. 2. Expressionpatterns ofHesr3 in the development of cochlea.E14.5 cochlea
(A) did not show Hesr3 signal in the developing sensory epithelium (white
arrowheads); however, lateral side of cochlea duct showed some expression
(bracket). Inset in panel A shows immunostaining of the same section with anti-
p27kip1. E16.5 (B) and E18.5 (C) samples clearly showed the expression ofHesr3
in the sensory epithelium (black arrowheads in panels B, C). Panel D shows P0
cochlea. Hesr3mRNAwas detected in the sensory epithelium and GER. Inset in
panel D shows immunostaining of the same section with anti-Myo6. Arrow
indicates inner hair cell. dc: Deiters' cells. pc: Pillar cells. Scale bar=50 μm.
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(2006) (see Fig. 3L).
Single deletions of either Hesr1 or Hesr2 do not disrupt
cochlear development
To determine whether the Hesr genes are the critical
downstream mediators of the prosensory function of the
Fig. 5. Hesr1 or Hesr2 null mice have normal organs of Corti at postnatal day 3.
The sensory epithelia from wild type (A), Hesr1−/− (B), and Hesr2−/− (C)
stained with Hematoxylin–Eosin (HE), GS-lectin (hair cells) and anti-Prox1
antibody (supporting cells). The organ of Corti of Hesr1 or Hesr2 knockout
mouse showed 4 rows of hair cells (one of inner and 3 of outer hair cells) and 5
rows of supporting cells (2 pillar and 3 Deiters' cells) similar to the wild type
littermates (A). ihc: Inner hair cells (arrows). ohc: Outer hair cells (arrowheads).
pc: Pillar cells. dc: Deiters' cells. Scale bar=20 μm.
Fig. 4. Hesr1/Hesr2 expression overlaps with p27kip1. In situ hybridization of
Hesr1 or Hesr2 and other genes expressed in the sensory epithelium were
counterstained with p27kip1 (C–I, E–J). In situ signal was detected in purple,
p27kip1 protein was in red fluorescence. A, C, E, G, I and K: adjacent sections of
E13.5 cochlear duct (middle part). Math1 was not yet expressed in this region
(K). B, D, F, H, J and L: Adjacent sections of the basal turn (turn1) of an E15.5
cochlea. Scale bar=100 μm.
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epithelia, we investigated the structure of the organ of Corti of
mice deficient in either Hesr1 or Hesr2. We harvested the
cochlea at postnatal day 3 from mice with targeted deletions to
these genes and their littermate controls (wild type). These
animals are on a C57bl/6,129sv mixed background (Kokubo et
al., 2005b). We labeled the organ of Corti for both supporting
cells with Prox1 (Bermingham-McDonogh et al., 2006) and hair
cells with GS-lectin (Kiernan et al., 2006). We found that the
organ of Corti of P3 Hesr1 null or Hesr2 null mice and wildtype mice had a single row of inner hair cells (Figs. 5A–C,
arrows) and three rows of outer hair cells (Figs. 5A–C,
brackets) along the entire length of the cochlear duct. The
differentiation and cellular patterning of supporting cells was
also normal as revealed by anti-Prox1 immunostaining and HE-
staining sections (Fig. 5). The absence of a phenotype could be
explained by the redundancy of Hesr1 and Hesr2 (also Hesr3
in the later stage), unfortunately, mice deficient in both Hesr1
and Hesr2 die between E9.5 and E11.5 (Fischer et al., 2004;
Kokubo et al., 2005a) due to cardiac and vascular defects,
precluding the analysis of the inner ear phenotype in these
animals.
Inhibition of Notch signaling at E12.5 suppresses sensory
epithelial development
To investigate the effect of inhibition of Notch-signaling
during the prosensory phase of cochlear development, we
prepared explant cultures of E12.5–E13.0 cochlear ducts, as
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secretase inhibitor, DAPT or TACE inhibitor, TAPI-1 (Brou et
al., 2000; Takebayashi et al., 2007) at varying concentrations
and for different time periods (Figs. 6–9). Both TACE and γ-
secretase are required for the generation of the active Notch
intracellular cleavage product that associates with RBPjK/SuH
to activate transcription of target genes.
The effects of Notch inhibition on sensory epithelial
development were assayed with antibodies to Myo6 (hair cell
marker), Sox2 (prosensory marker) and Prox1 (supporting cell
marker). Cultures treated with 25 μM DAPT for 3 days and
harvested at 6 days showed an 85% reduction in the number of
hair cells (Figs. 6B, C). When 50 μMDAPTwas included in the
media for 3 days, or the entire culture period, most hair cell
development was suppressed (Figs. 6B, C and 7A). Supporting
cell development was also inhibited with DAPT treatment, as
indicated by the lack of Prox1 immunolabeled cells (Fig. 7B).
Interestingly, Sox2 was still expressed in the apex of the
presumptive sensory epithelial domain in the DAPT treated
cultures (Fig. 7C), but the number of Sox2 labeled cells was
reduced about 50% compared with the untreated cultures (176±
12/100 μm2 in control vs. 96±27 in DAPT treated). In addition
we saw an even more dramatic decrease in Sox2 cells in the base
of the explants (150±21 in control vs. 12±19 in DAPT treated)
(Fig. 7C). The reduction in hair and support cells was not due to
an effect on cell survival, since we found very little cell death
within the developing sensory epithelial region in either the
DAPTor control explants when we labeled apoptotic cells using
a TUNEL assay (7±4.6 apoptotic cells in control and 8±5.3 in
DAPT treated cultures). We also treated cultures with the TACE
inhibitor, TAPI-1. We found that TAPI-1 treatment caused a
similar reduction in hair cells in a dose dependent manner
(Figs. 8B, C). At a low concentration of TAPI-1 (20 μM),
inhibition of hair cell development was moderate resulting in aFig. 6. DAPT treatment inhibits hair cell differentiation. Schematic of culture method
were cultured with surrounding mesenchyme on collagen/Matrigel (A). The cochle
DAPT for 2 different durations (B), and hair cells were counted after 6 days in vitro
DAPT according the time schedule in panel A. Error bars indicate standard deviat
asterisk indicate Pb0.005 compared to the control with a Student's T-test.50% decrease; however, when TAPI-1 was combined with a
low concentration (5 μM) of DAPT (which alone reduces the
hair number by 50%), we observed a synergistic effect, resulting
in a more than 90% reduction in hair cells (Figs. 8B,D). These
results confirm earlier studies showing a role for Notch
signaling in the prosensory specification step of cochlear
development (Kiernan et al., 2006).
To test whether Hesr1 and/or Hesr2 were regulated by
Notch during the prosensory phase of cochlear development,
E12.5–E13.0 cochlea ducts were cultured with or without
DAPT for 12 or 24 h and then mRNA levels of Hesr1 and
Hesr2 were compared using Q-PCR. We found that both Hesr1
and Hesr2 were down-regulated in DAPT treated explants after
12–24 h; however, Hesr1 showed a greater change (Fig. 7D).
These results support the possibility that Hesr1 and/or Hesr2
may act as effectors of the prosensory function of Notch during
cochlear development.
The early treatment with Notch inhibitors allowed us to see
the prosensory function in mouse cochlea. However, it has been
previously shown that inhibition of Notch later in development
results in an overproduction of hair cells, due to the lack of
lateral inhibition. We therefore designed a series of experiments
to allow us to identify the prosensory period. For these
experiments, we separated the E12.5/13 cochlear explants into
four DAPT treatment groups, 0–2 DIV, 0–3 DIV 3–6 DIV and
4–6 DIV (Fig. 9A). Treatment of the cultures with DAPT from
0–2 or 0–3 days reduced the numbers of developing hair cells,
with the greatest loss occurring when the cultures were treated
for 3 days (Figs. 6C and 9B). These results show that the
prosensory period extends to at least E15.5/16.
We also analyzed the effects of Notch inhibition at later
stages of cochlear development to confirm its role in lateral
inhibition. When E12.5–13.0 cochlear explants were cultured
for 4 days prior to addition of DAPT (4–6 DIV group, Fig. 9A),and experimental design of DAPT treatments (A, B). E12.5–13.0 cochlear ducts
as were separated into control and incubated with 3 different concentrations of
(DIV). (C) Number of hair cells in a cochlea cultured for 6 days with or without
ions of the means. N=number of cochleas. Asterisk indicates Pb0.05, double
Fig. 7. DAPT treatment down-regulated Hesr1/2 expression, and inhibited sensory epithelium development. (A–C) Explant cultures treated with DAPT for 6 days in
vitro (see panel A), and stained with anti-Myo6 (A), Prox1 (B) and Sox2 (C). Basal end is to the right, the apex is to the left. (D) Hesr1 and Hesr2 mRNA levels of
cochleas treated with DAPT (magenta bars) for 12 or 24 h were compared with control cultures (no DAPT, blue bars). Error bars indicate standard deviations of the
means. Asterisk indicates Pb0.05, double asterisk indicate Pb0.005 compared to the control with a Student's T-test. The number of explants (N) is indicated above
each panel. Scale bar=100 μm.
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1387±341 hair cells/cochlear explant (Figs. 9B, D) when we
treated the explants with 50 uM DAPT, and 1343±235 hair
cells (N=6) in explants treated with 5 uM DAPT compared to
controls: 944±273. These results confirm previous reports and
suggest that a lower concentration of DAPT is required to
inhibit Notch dependent signaling during the lateral inhibition
phase when compared with the prosensory phase.
In the course of these experiments, we also noticed that
explants cultured at intermediate times of development
displayed aspects of both Notch-dependent phenotypes. In
cultures treated with DAPT from 3 to 6 DIV, we found an
increase in hair cells in the base of the explant (83±15.3/
100 μm2) and a decrease in hair cells in the apex (11±6.6/
100 μm2) relative to untreated cultures (base, 66±13.0/100 μm2: apex, 41±14.3/100 μm2). Thus, both the prosensory
function and the lateral inhibitory function of Notch could be
blocked in a single explant in different regions of the developing
cochlea (Fig. 9C). These results suggest that the prosensory
function of Notch proceeds from base to apex, and may still be
active in the apex as late as E16.
Since TACE and γ-secretase are necessary for the processing
of other cell surface proteins we devised a method of inhibiting
notch signaling that was independent of processing. Master-
mind (Mam) was identified as a regulator of the Notch signaling
pathway by genetic studies in Drosophila (Schweisguth and
Posakony, 1992). Homologous proteins, called Mastermind-
like (MAML) have been shown in vertebrates to stabilize the
DNA binding complex of the Notch ICD and CSL (Wu et al.,
2000). Truncated versions of hMam-1 that retain the N-terminal
Fig. 8. Inhibition of TACE also inhibits hair cell development. (A) Experimental
design of the TAPI-1 treatment of cochlear cultures. The explants were separated
into control and 4 different treatment groups. DIV: days in vitro. (B) Hair cell
counts after treatment with various concentrations of TAPI-1. (C, D) Explant
cultures were treated with 100 μM TAPI-1 (C) or 20 μM TAPI-1 plus 5 μM
DAPT (D), and stained with anti-Myo6. Error bars indicate standard deviations
of the means. N=number of cochleas. Asterisk indicates Pb0.05, double
asterisk indicate Pb0.005 compared to the control with a Student's T-test.
Fig. 9. Change in the number of hair cells that develop in the cochleae cultured
with DAPT for different durations. (A) Experimental design of the DAPT
treatment of cochlear culture. The cochleas were separated into control and 4
different treatment groups. DIV: days in vitro. (B) Number of hair cells in a
cochlea cultured for 6 days with or without DAPTaccording to the time schedule
in panel A. Error bars indicate standard deviations of the means. N=number of
cochleas. Asterisk indicates Pb0.05, double asterisk indicate Pb0.005
compared to the control with a Student's T-test. (C, D) anti-Myo6 staining of
cochlea in middle (C) or late (D) treatment group. The basal end of the ducts are
to the right, the apex is to the left. White box shows the sensory epithelium from
the basal send of the explant and dashed box shows the apical region. Scale
bar=100 μm.
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negative fashion and inhibit Notch signaling (Kitagawa et al.,
2001). We have used such a truncated version of MAML-1
(DN-MAML-1) to determine whether the effects we have
observed with the γ-secretase and TACE inhibitors are specific
to the Notch pathway. We expressed the DN-MAML-1
(Maillard et al., 2006) in a construct with IRES-GFP to
visualize the transfected cells. Cochlear explants were preparedfrom embryos at E13.5 and the DN-MAML-1 and GFP control
constructs were transfected by electroporation. Following
electroporation, the explants were cultured for 3 days to allow
time for the expression of the constructs and development of the
sensory epithelium. The explants were then processed for
immunofluorescence using antibodies to Sox2 and MyoVI. As
96 T. Hayashi et al. / Developmental Biology 316 (2008) 87–99shown in Supplementary Figs. 2A–D and 3A–D, we found that
regions of the presumptive sensory epithelium that were
efficiently transfected with DN-MAML-1 showed clear disrup-
tions in the pattern of hair cells (MyoVI+). In some cases, we
found that the hair cells in these regions formed rosette-like
patterns, while in other cases there was a clear lack of hair cells
in the transfected region. We also found disruptions in Sox2+
cells (not shown); in regions of effective transfection, there were
gaps in the Sox2 labeling. In all cases (8/8) we found
disruptions and defects in sensory epithelial development in
explants transfected with DN-MAML-1. These disruptions in
hair cell development or Sox2 patterning were not observed in
the pMes-GFP-control transfected explants (Supplementary
Figs. 4A,B). These results are consistent with a prosensory role
of Notch signaling in mouse cochlear development and confirm
the observations with inhibitors DAPT and TAPI-1.
Discussion
We have found that Hesr1, Hesr2 and Hesr3 are expressed
within the developing organ of Corti. A previous analysis of
Hesr expression during mouse embryogenesis reported that
Hesr1 and Hesr2 are expressed in the otic vesicle at E9.5 and
later in the cochlear epithelium at E17.5 (Leimeister et al.,
1999). Our study confirms and extends this earlier report by
providing a more detailed analysis of the expression pattern and
identifying a possible role for these gene products as potential
downstream mediators of prosensory Notch signaling. In
addition, we have found that inhibition of the Notch signaling
pathway with either a γ-secretase inhibitor (DAPT) or a TACE
inhibitor (TAPI-1) at different stages of cochlear development,
clearly separates the two distinct functions of Notch. This
allows dissection of the spatio-temporal gradient in Notch
function: at late stages of development, inhibition of NotchFig. 10. Schematic of development of sensory epithelium in cochlea. The developmen
phase, Notch has a prosensory role allowing the specification of the sensory doma
surrounding cells to differentiate hair cells (B). Pro-SE: Prosensory epithelium. SE:promotes hair cell differentiation, confirming earlier reports
(Tang et al., 2005; Yamamoto et al., 2006), while at early stages
of development, we report for the first time that small molecule
inhibitors of the Notch pathway can inhibit the prosensory
phase of development in the mammalian cochlea.
The Notch signaling system is required at several distinct
phases of cochlear development (Fig. 10). Our results suggest
that different downstream effectors may mediate the distinct
developmental effects. The earliest “prosensory phase” requires
the Notch ligand Jag1 (Brooker et al., 2006; Kiernan et al.,
2006; Morrison et al., 1999; Tsai et al., 2001; Kiernan et al.,
2006 #1651). Hesr1 and Hesr2 are good candidates for
downstream effectors of Jag1/Notch signaling during this
early prosensory period, while Hes1 and Hes5 appear to be
involved only at later stages of cochlear development. While we
did not detect Hes1 or Hes5 at this early stage of Notch
signaling, the expression of both Hesr1 and Hesr2 in the
developing cochlear duct coincides with the timing of an early
prosensory function for these genes. The expression pattern of
Hesr1 and Hesr2 can be compared spatially and temporally
with Jag1 expression and the zone of active Notch signaling as
shown by immunolabeling for the NotchICD (Del Monte et al.,
2007; Murata et al., 2006). The expression of Hesr2
corresponds closely with that of ActN-ICD at early stages of
cochlear development (E13.5–E15.5), as reported by Murata et
al. (2006). However, the expression of Jag1 is more medial and
only partly overlaps with the domain of Hesr2 and ActN-ICD.
By contrast, Hesr1 expression more closely corresponds with
that of Jag1, and thus not entirely overlapping with the reported
expression of ActN-ICD. Interestingly, Hesr1 responds more
rapidly to Notch inhibition than Hesr2 (Fig. 7D), and so it is
possible that a lower level of Jag1/Notch signaling is required
for Hesr1 expression and my not be detected by the ActN-ICD
antibody. It is also possible that Jag1 also acts through anothert of sensory epithelium is separated into early (A) and later (B) phase. In the early
in (A). After hair cell specification, Notch ligand expressing hair cells inhibit
Sensory epithelium. hc: Hair cells. sc: Supporting cells.
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does not recognize the cleavage site of the other Notch receptors
(Del Monte et al., 2007). Thus, Jag1/Notch2 signaling might
regulate expression of Hesr1, while Jag1/Notch1 signaling
might regulateHesr2. These partly redundant signals might thus
explain why conditional deletion of Notch1 failed to show a
prosensory phenotype (Kiernan et al., 2005). Thus, although we
have shown that both of these genes are potential downstream
targets of Notch signaling in early cochlear development, they
appear to have slightly different expression patterns.
The effectors of the lateral inhibitory phase of cochlear
development (Fig. 10) are more well-established. The Hes
genes are expressed only at later stages of development
(Lanford et al., 2000; Zheng et al., 2000; Zine et al., 2001)
and loss of function mutations result in increased numbers of
hair cells, consistent with a role in lateral inhibition. However,
we have also found that Hesr3 is expressed in support cells at
later stages (E16) of cochlear development, and so this gene
may also play a role in lateral inhibition. In fact the relatively
minor phenotypes observed in the Hes1 and Hes5 knockout
mice (see above) suggests that another Notch effector may be
involved in these later stages of cochlear development, and
Hesr3 is expressed at the right time and place to serve this role.
We have also found that blocking the Notch signal during the
prosensory period, with either the γ-secretase inhibitor, DAPT,
or the TACE inhibitor TAPI-1, recapitulates the effects of Jag1
mutations/deletions reported previously. DAPT causes a
significant reduction of both Hesr1 and Hesr2, to as little as
20% of the expression levels in untreated control cultures.
Interestingly, Jag1 over-expression has been shown to up-
regulate Hesr2 expression in C2C12 myoblasts (Iso et al.,
2003). In addition to demonstrating that Hesr1 and Hesr2 are
regulated by early Notch signaling our results in explant
cultures confirm a role for Notch as a prosensory signal. Two
other recent studies have used DAPT to identify distinct
temporal phases during cochlear development where Notch is
required. In the developing chick otocyst, Daudet et al. (2007)
found that continuous DAPT treatment of explant cultures
caused a significant reduction in the size of sensory epithelial
patches, and concomitant reduction in hair cell numbers, thus
confirming a prosensory role for Notch signaling. Takebayashi
et al. (2007) used DAPT treatment of mouse cochlear cultures to
identify additional roles for Notch; in addition to its role in
lateral inhibition, they found that Notch signaling is also
required for supporting cell differentiation (Prox1 expression)
and the maintenance of their phenotype (Takebayashi et al.,
2007). Moreover, they reported that Notch signaling also
promotes cell cycle withdrawal and p27kip expression. Our
results highlight aspects of both of these studies. We find that
blocking Notch in E12.5 mouse cochlear explants inhibits
sensory epithelial formation similar to that described in the
chick embryo explant cultures (Daudet et al., 2007). With
continuous DAPT treatment, both Prox1 and Myo6 expressing
cells are almost completely lost (Figs. 6 and 7). We found, as did
Takebayashi et al. (2007) that DAPT treatment of mouse
cochlear explant cultures at later stages of development results
in an overproduction of hair cells (Figs. 8B and C). Althoughboth TACE and γ-secretase are known to be involved in the
processing of several other signaling proteins and receptors
(Ebinu and Yankner, 2002), our results, along with those of
Daudet et al. (2007) and the conditional deletion of Jag1
(Kiernan et al., 2006; Brooker et al., 2006) suggest that the
inhibitors we used are primarily acting through the Notch
pathway.
A key difference between our results and those of
Takebayashi et al. (2007) is that we were able to demonstrate
the prosensory function of Notch in our cultures and they were
not. The explant cultures that we used are quite similar to those
described in their study; however, while we found a significant
effect of DAPT at 5 μM, a higher dose of DAPT (50 μM) is
required to fully inhibit the prosensory function of Notch. By
contrast, the lateral inhibitory function of Notch can be fully
inhibited with only 5 μM DAPT. In addition, to see the full
effect of inhibition during the prosensory phase of development,
we needed to treat the cultures for 3 days (Figs. 9A, B), while
Takebayashi et al. (2007) treated cultures at a low concentration
of inhibitor (5 μM) and for only 2 days. Interestingly, Daudet et
al. (2007) used up to 100 μM in their experiments, and this was
required to block all Hes expression in the chick embryo
cultures. In addition, Abello et al. have shown that in order to
obtain consistent results, with DAPT inhibition of notch
signaling, they needed to use 100 μM in explant cultures
(Abello et al., 2007). This may be due to the difficulty of getting
an effective dose into relatively large pieces of tissue.
We also find that Sox2 is reduced in the presumptive sensory
epithelial domain following DAPT treatment, consistent with
recent reports of conditional Jag1 deletions. Kiernan et al.
(2006) found that conditional deletion of Jag1 using the
FoxG1-cre resulted in a significant reduction in Sox2 expres-
sion. The base of the cochlea was more severely affected than
the apex, where Sox2 expression was still detected. We have
found that DAPT treatment causes a very similar result, with
Sox2 largely absent from the base and substantially reduced in
the apex. This is consistent with recent models of cochlear
development that propose the progression of sensory epithelial
development (i.e. hair cells and supporting cells), though not its
initial induction (e.g. Sox2 and Jag1/Serrate expression), are
dependent on Notch signaling (Daudet et al., 2007; Kiernan et
al., 2005; Kiernan et al., 2006).
Taken together, our data support a role for Hesr1 and/or
Hesr2 as downstream effectors of the prosensory Jag1 signal
in the cochlea; however, a preliminary analysis of the Hesr1 and
Hesr2 deficient mice failed to show any defects in the
development of the hair cells or supporting cells in the organ
of Corti. This may be due to a functional redundancy in these
genes, since they are expressed in largely overlapping domains
during most of cochlear development. This is a difficult
hypothesis to test, since animals deficient in both Hesr1 and
Hesr2 die early in embryonic development, prior to differentia-
tion of the organ of Corti. Analysis of conditional deletions of
these genes will ultimately be necessary. Alternatively, it may
be that another member of the Hes family of proteins, such as
Hes1 or Hes5 serve a prosensory function when Hesr1 or
Hesr2 are deleted. However, there is a key difference between
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by recruiting co-repressors, Hes proteins recruit Groucho via
the WRPW domain in the C-terminus, while Hesr proteins have
a YRPW instead and do not appear to interact with the same co-
repressors, but instead their bHLH and Orange domains are
important for recruiting the Sin3/SMRT co-repression complex.
Additional experiments, using conditional mutations, will be
needed to test whether the Hesr genes are redundant with one
another in the developing cochlea (Fischer and Gessler, 2007).
It is interesting that Hesr1 and Hesr2 (Hesr3 in the later
stage) are expressed in the cochlea sensory epithelium, while
Hesr1 and Hesr3 are expressed in the vestibular sensory
patches. In many tissues, there is a mutual exclusivity of Hesr1
and Hesr2; in the developing heart for example, Hesr1 is
expressed in the ventricles while Hesr2 is expressed in the atria
(Fischer and Gessler, 2003). This complementary expression
pattern has led to the proposal that the Hesr gene products cross-
repress one another (Iso et al., 2003). In the inner ear, it may be
that Hesr2 and Hesr3 cross-repress one another in the auditory
and vestibular epithelium, respectively, and this may lead to
their lack of mutual expression. By contrast, Hesr1 can
apparently be co-expressed with either Hesr2 or Hesr3.
In conclusion, we have shown that Hesr1 and Hesr2 are
expressed at the right time and place to act as mediators of the
prosensory function of Notch in the developing cochlea.
Moreover, these two genes are regulated by Notch in the early
stages of cochlea development, prior to the expression of Hes1
or Hes5. We have also found that the inhibition of Notch over
precisely defined periods of cochlear development is a powerful
way to dissect the various roles for this signaling system in
development. For example, in a single explant, we found a
reduction in the hair cells in the apex but an overproduction of
hair cells in the base, reflecting the relative state of differentia-
tion of the epithelium at each position, and allowing dissection
of the spatio-temporal gradients in Notch function.
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